Laith Al‐Rabadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Laith Al‐Rabadi has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Namrata Singhania
Department of Hospital Medicine Mount Carmel East Hospital Columbus OH USA
2 shared publicationsAnil K. Singh
Department of Internal Medicine Geisinger Community Medical Center Scranton Pennsylvania
1 shared publicationAnil Kumar Singh
Department of Internal Medicine Geisinger Community Medical Center Scranton PA USA
1 shared publicationAnil Singh
Geisinger-Community Medical
1 shared publicationChandra Mouli Nukala
Department of Hospital Medicine CHI St Vincent Infirmary Little Rock AR USA
1 shared publicationChandra Nukala
CHI St Vincent Infirmary
1 shared publication
Latest Publications
- Open Access
- 19 January 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (3) , 1466-1468
Histoplasma stomatitis unveiled: Not all opportunistic infections get better after initiation of antiretroviral therapy
Immune reconstitution inflammatory syndrome in AIDS patients can lead to an initial worsening of underlying diseases due to body's ability to mount a strong immune response after recovery of CD4 counts.
- 19 January 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (3) , 1466-1468
Open AccessHistoplasma stomatitis unveiled: Not all opportunistic infections get better after initiation of antiretroviral therapy
Immune reconstitution inflammatory syndrome in AIDS patients can lead to an initial worsening of underlying diseases due to body's ability to mount a strong immune response after recovery of CD4 counts.
- Open Access
- 2 November 2020
- Published by Wiley
HISTOPLASMA STOMATITIS UNVEILED: Not all opportunistic infections get better after initiation of antiretroviral therapy
Histoplasmosis occurs primarily in the lungs but can disseminate in immunocompromised patients. Serology can be negative in patients with local infection, making the diagnosis challenging. Definite diagnosis is by microscopic examination of the tissue sample. We report a rare case of Histoplasma stomatitis whose lesions manifested after initiating antiretroviral therapy.
- 2 November 2020
- Published by Wiley
Open AccessHISTOPLASMA STOMATITIS UNVEILED: Not all opportunistic infections get better after initiation of antiretroviral therapy
Histoplasmosis occurs primarily in the lungs but can disseminate in immunocompromised patients. Serology can be negative in patients with local infection, making the diagnosis challenging. Definite diagnosis is by microscopic examination of the tissue sample. We report a rare case of Histoplasma stomatitis whose lesions manifested after initiating antiretroviral therapy.
- Open Access
- 12 March 2020
- Published by Wiley in Clinical Case Reports
- Vol. 8 (4) , 722-724
Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal
Development of acute abdominal pain after Kayexalate and activated charcoal administration should prompt clinician to consider intestinal necrosis. Concomitant use should be avoided to minimize the risk of this devastating but preventable condition.
- 12 March 2020
- Published by Wiley in Clinical Case Reports
- Vol. 8 (4) , 722-724
Open AccessIntestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal
Development of acute abdominal pain after Kayexalate and activated charcoal administration should prompt clinician to consider intestinal necrosis. Concomitant use should be avoided to minimize the risk of this devastating but preventable condition.
- Open Access
- 3 November 2015
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 8 (6) , 722-728
Proliferative glomerulonephritis with monoclonal immunoglobulin in renal allografts
Glomerulopathy due to dysproteinemia can have a wide spectrum of pathologic and clinical features based on specific characteristics of the abnormal protein and the response induced within the parenchymal tissue. Monoclonal immunoglobulin G (IgG) deposition can manifest as a different glomerular disease. Proliferative glomerulonephritis (GN) with monoclonal IgG deposits (PGNMID) is a unique entity mimicking immune complex GN that does not conform to any of those subtypes. IgG monoclonal granular deposition in the glomeruli with a pattern similar to immune complex disease suggested by C3 and C1q deposition should prompt consideration of PGNMID. Literature is scarce in terms of recurrence of disease in renal allografts. In this article we present the clinical–pathologic features of three cases of PGNMID in the renal allograft showing the variable course and manifestation of the disease.
- 3 November 2015
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 8 (6) , 722-728
Open AccessProliferative glomerulonephritis with monoclonal immunoglobulin in renal allografts
Glomerulopathy due to dysproteinemia can have a wide spectrum of pathologic and clinical features based on specific characteristics of the abnormal protein and the response induced within the parenchymal tissue. Monoclonal immunoglobulin G (IgG) deposition can manifest as a different glomerular disease. Proliferative glomerulonephritis (GN) with monoclonal IgG deposits (PGNMID) is a unique entity mimicking immune complex GN that does not conform to any of those subtypes. IgG monoclonal granular deposition in the glomeruli with a pattern similar to immune complex disease suggested by C3 and C1q deposition should prompt consideration of PGNMID. Literature is scarce in terms of recurrence of disease in renal allografts. In this article we present the clinical–pathologic features of three cases of PGNMID in the renal allograft showing the variable course and manifestation of the disease.